

Enlivex's RAIN token begins trading on KuCoin as analysts raise price targets, citing growing prediction markets and token burn mechanics.
You can purchase shares of Enlivex (NASDAQ:ENLV) through any online brokerage.
Other companies in Enlivex’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Enlivex has a consensus price target of $2200.00.
The stock price for Enlivex (NASDAQ: ENLV) is $1.212 last updated November 18, 2026 at 1:05 PM EST.
There are no upcoming dividends for Enlivex.
Enlivex does not have any upcoming earnings scheduled.
There is no upcoming split for Enlivex.
Enlivex is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a...